The House Energy and Commerce Health Subcommittee has scheduled a November 17, 2015 hearing on the regulation of diagnostic tests and laboratory operations. The hearing will feature FDA and CMS officials who will testify on "each agency's respective responsibilities and areas of expertise in the regulation of diagnostic tests, as well as what their roles should entail going forward." In connection with the hearing, the Subcommittee is soliciting feedback on an updated discussion draft of legislation addressing the regulation of in vitro clinical tests.
This article is presented for informational purposes only and is not intended to constitute legal advice.